Full history for every metric is available with a Kvantra account
PetIQ, Inc. (PETQ)
Key financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 529 | 709 | 780 | 933 | 922 | 1,102 | 1,134 |
| Operating profit | $m | 60 | 65 | |||||
| Net profit | $m | -1 | -14 | -81 | -16 | -49 | 2 | 13 |
| EPS reported | $ | 0.07 | 0.29 | |||||
| Operating cashflow per share | $ | 2.12 | 2.12 | |||||
| Capex per share | $ | 0.31 | 0.31 | |||||
| FCF per share | $ | 1.81 | 1.81 | |||||
| Free cash flow | $m | 53 | 12 | |||||
| Net debt | $m | 338 | 358 | |||||
| Book value equity | $m | 221 | 258 | |||||
| Book value per share | $ | 7.49 | 7.38 | |||||
| Number of shares | m | 29.53 | 34.94 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 273.55 | - | |||||
| P/B LTM | x | 2.60 | 3.56 | |||||
| P/S LTM | x | 0.52 | 0.81 | |||||
| P/FCF LTM | x | 10.91 | 76.73 | |||||
| EV/EBITDA LTM | x | 11.47 | 13.71 | |||||
| EV/Sales LTM | x | 0.85 | 1.13 | |||||
| Earnings Yield LTM | % | 0.37% | 0.24% | |||||
| FCF Yield | % | 9.17% | 1.30% | |||||
| Quality | ||||||||
| ROE | % | 0.96% | 0.99% | |||||
| ROIC | % | 8.54% | 8.54% | |||||
| Operating margin | % | 5.45% | 5.45% | |||||
| Gross margin | % | 22.94% | 22.94% | |||||
| FCF/Sales | % | 4.79% | 4.79% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +19.58% | +13.57% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | +46.30% | -89.99% | |||||
| Operating Profit Growth | % | +120.38% | +86.04% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 0.11 | 0.03 | |||||
| Net Debt/EBITDA | x | 4.41 | 4.41 | |||||
| EBIT/Net interest | x | 1.74 | 1.74 | |||||
| Net debt/market cap | % | 58.68% | 38.92% | |||||
| Net debt/Equity | x | 1.53 | 1.39 | |||||
| Gross debt/equity | x | 2.15 | 1.76 | |||||
Company overview
PetIQ, Inc. operates as a prominent enterprise in the pet health and wellness sector, with a market presence across the United States and internationally. Its operations are strategically divided into two primary segments: Products and Services. Within its Products division, the company provides a comprehensive range of veterinary prescription medications. This includes crucial treatments for issues like flea and tick control, heartworm prevention, arthritis, thyroid disorders, diabetes management, pain relief, various antibiotics, and other specialized pharmaceuticals. PetIQ is unique in that it both develops and manufactures its own line of exclusive, value-branded products, while also serving as a distributor for numerous established third-party branded medications. Furthermore, it supplies over-the-counter (OTC) medications and related supplies, with a strong emphasis on flea and tick control and behavior management solutions. These OTC offerings are available in diverse formats, such as topical spot-on applications, chewable and oral tablets, and collars. Beyond medications, the company also features health and wellness products, including specialized dental treats and a variety of nutritional supplements for concerns like hip and joint health, general vitamins, and improvements to skin and coat. This extensive product portfolio is marketed under a wide array of brand names, including PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles. The Services segment delivers an extensive suite of veterinary care options. PetIQ manages approximately 2,900 community clinics and wellness centers, frequently hosted within pet retail locations across 42 states. These centers provide essential services such as diagnostic testing, comprehensive vaccination programs, dispensing of prescription medications, microchipping, and routine wellness examinations. With an impressive reach, PetIQ leverages approximately 60,000 distribution points, ensuring its products and services are readily available through diverse channels, including veterinary practices, traditional retail stores, and online e-commerce platforms. Established in 2010, PetIQ, Inc. is headquartered in Eagle, Idaho.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
PetIQ, Inc. (PETQ)
PetIQ, Inc. operates as a prominent enterprise in the pet health and wellness sector, with a market presence across the United States and internationally. Its operations are strategically divided into two primary segments: Products and Services. Within its Products division, the company provides a comprehensive range of veterinary prescription medications. This includes crucial treatments for issues like flea and tick control, heartworm prevention, arthritis, thyroid disorders, diabetes management, pain relief, various antibiotics, and other specialized pharmaceuticals. PetIQ is unique in that it both develops and manufactures its own line of exclusive, value-branded products, while also serving as a distributor for numerous established third-party branded medications. Furthermore, it supplies over-the-counter (OTC) medications and related supplies, with a strong emphasis on flea and tick control and behavior management solutions. These OTC offerings are available in diverse formats, such as topical spot-on applications, chewable and oral tablets, and collars. Beyond medications, the company also features health and wellness products, including specialized dental treats and a variety of nutritional supplements for concerns like hip and joint health, general vitamins, and improvements to skin and coat. This extensive product portfolio is marketed under a wide array of brand names, including PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles. The Services segment delivers an extensive suite of veterinary care options. PetIQ manages approximately 2,900 community clinics and wellness centers, frequently hosted within pet retail locations across 42 states. These centers provide essential services such as diagnostic testing, comprehensive vaccination programs, dispensing of prescription medications, microchipping, and routine wellness examinations. With an impressive reach, PetIQ leverages approximately 60,000 distribution points, ensuring its products and services are readily available through diverse channels, including veterinary practices, traditional retail stores, and online e-commerce platforms. Established in 2010, PetIQ, Inc. is headquartered in Eagle, Idaho.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free